-
1
-
-
0037083098
-
Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
-
Jiang Z.D., Lowe B., Verenkar M.P., Ashley D., Steffen R., Tornieporth N., et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185 (2002) 497-502
-
(2002)
J Infect Dis
, vol.185
, pp. 497-502
-
-
Jiang, Z.D.1
Lowe, B.2
Verenkar, M.P.3
Ashley, D.4
Steffen, R.5
Tornieporth, N.6
-
2
-
-
0035576899
-
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial
-
DuPont H.L., Jiang Z.D., Ericsson C.D., Adachi J.A., Mathewson J.J., DuPont M.W., et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 33 (2001) 1807-1815
-
(2001)
Clin Infect Dis
, vol.33
, pp. 1807-1815
-
-
DuPont, H.L.1
Jiang, Z.D.2
Ericsson, C.D.3
Adachi, J.A.4
Mathewson, J.J.5
DuPont, M.W.6
-
3
-
-
0035164505
-
In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions
-
Gomi H., Jiang Z.D., Adachi J.A., Ashley D., Lowe B., Verenkar M.P., et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 45 (2001) 212-216
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 212-216
-
-
Gomi, H.1
Jiang, Z.D.2
Adachi, J.A.3
Ashley, D.4
Lowe, B.5
Verenkar, M.P.6
-
4
-
-
9444286424
-
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci
-
DuPont H.L., and Jiang Z.D. Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci. Clin Microbiol Infect 10 (2004) 1009-1011
-
(2004)
Clin Microbiol Infect
, vol.10
, pp. 1009-1011
-
-
DuPont, H.L.1
Jiang, Z.D.2
-
5
-
-
28044438912
-
Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin
-
DuPont H.L., Jiang Z.D., Okhuysen P.C., Ericsson C.D., de la Cabada F.J., Ke S., et al. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis 41 Suppl. 8 (2005) S571-S576
-
(2005)
Clin Infect Dis
, vol.41
, Issue.SUPPL. 8
-
-
DuPont, H.L.1
Jiang, Z.D.2
Okhuysen, P.C.3
Ericsson, C.D.4
de la Cabada, F.J.5
Ke, S.6
-
6
-
-
0033943939
-
In vitro activity and fecal concentration of rifaximin after oral administration
-
Jiang Z.D., Ke S., Palazzini E., Riopel L., and Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother 44 (2000) 2205-2206
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2205-2206
-
-
Jiang, Z.D.1
Ke, S.2
Palazzini, E.3
Riopel, L.4
Dupont, H.5
-
7
-
-
0015616521
-
Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli
-
Riva S., Fietta A., Berti M., Silvestri L.G., and Romero E. Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli. Antimicrob Agents Chemother 3 (1973) 456-462
-
(1973)
Antimicrob Agents Chemother
, vol.3
, pp. 456-462
-
-
Riva, S.1
Fietta, A.2
Berti, M.3
Silvestri, L.G.4
Romero, E.5
-
8
-
-
0003344510
-
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard
-
Clinical and Laboratory Standards Institute, 7th ed, Wayne, PA: CLSI
-
Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI, 2006.
-
(2006)
Document
-
-
-
9
-
-
0018854046
-
Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
-
Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102 (1980) 196-202
-
(1980)
Anal Biochem
, vol.102
, pp. 196-202
-
-
Heussen, C.1
Dowdle, E.B.2
-
10
-
-
2442660400
-
Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli
-
Huang D.B., DuPont H.L., Jiang Z.D., Carlin L., and Okhuysen P.C. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol 11 (2004) 548-551
-
(2004)
Clin Diagn Lab Immunol
, vol.11
, pp. 548-551
-
-
Huang, D.B.1
DuPont, H.L.2
Jiang, Z.D.3
Carlin, L.4
Okhuysen, P.C.5
-
11
-
-
0035694212
-
Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro
-
Miyajima S., Akaike T., Matsumoto K., Okamoto T., Yoshitake J., Hayashida K., et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 31 (2001) 271-281
-
(2001)
Microb Pathog
, vol.31
, pp. 271-281
-
-
Miyajima, S.1
Akaike, T.2
Matsumoto, K.3
Okamoto, T.4
Yoshitake, J.5
Hayashida, K.6
-
12
-
-
0034861026
-
Production of matrix metalloproteinases in response to mycobacterial infection
-
Quiding-Jarbrink M., Smith D.A., and Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 69 (2001) 5661-5670
-
(2001)
Infect Immun
, vol.69
, pp. 5661-5670
-
-
Quiding-Jarbrink, M.1
Smith, D.A.2
Bancroft, G.J.3
-
13
-
-
33748638853
-
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation
-
Sorsa T., Tjäderhane L., Konttinen Y.T., Lauhio A., Salo T., Lee H.M., et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38 (2006) 306-321
-
(2006)
Ann Med
, vol.38
, pp. 306-321
-
-
Sorsa, T.1
Tjäderhane, L.2
Konttinen, Y.T.3
Lauhio, A.4
Salo, T.5
Lee, H.M.6
-
14
-
-
0023276462
-
In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.
-
Ripa S., Mignini F., Prenna M., and Falcioni E. In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. Drugs Exp Clin Res 13 (1987) 483-488
-
(1987)
Drugs Exp Clin Res
, vol.13
, pp. 483-488
-
-
Ripa, S.1
Mignini, F.2
Prenna, M.3
Falcioni, E.4
-
15
-
-
33746042653
-
A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea
-
Taylor D.N., Bourgeois A.L., Ericsson C.D., Steffen R., Jiang Z.D., Halpern J., et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 74 (2006) 1060-1066
-
(2006)
Am J Trop Med Hyg
, vol.74
, pp. 1060-1066
-
-
Taylor, D.N.1
Bourgeois, A.L.2
Ericsson, C.D.3
Steffen, R.4
Jiang, Z.D.5
Halpern, J.6
|